Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Atreca raises $56mm through oversubscribed Series A

Executive Summary

Atreca Inc. (developing therapies based on the study of immune response) raised $56mm through its oversubscribed Series A round. A large US healthcare-focused fund led and was joined by the Bill & Melinda Gates Foundation, Mission Bay Capital, and GlaxoSmithKline. Brookline Group was the placement agent.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies